EF
JAZZ icon

Empowered Funds’s Jazz Pharmaceuticals JAZZ Stock Holding History

Empowered Funds’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.69M Buy
14,236
+362
+3% +$63.3K 0.02% 936
2025
Q4 		$2.36M Sell
13,874
-1,095
-7% -$168K 0.04% 438
2025
Q3 		$1.97M Buy
14,969
+1,530
+11% +$184K 0.02% 926
2025
Q2 		$1.43M Buy
+13,439
New +$1.46M 0.02% 956
2024
Q1 		– Sell
-18,562
Closed -$2.28M – 1409
2023
Q4 		$2.28M Buy
18,562
+131
+0.7% +$16.3K 0.06% 479
2023
Q3 		$2.39M Buy
+18,431
New +$2.46M 0.07% 398

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Empowered Funds's JAZZ Position: Q1 2026 in Review

Empowered Funds increased its Jazz Pharmaceuticals (JAZZ) stake by 2.6% in Q1 2026, buying an estimated $63.3K and bringing the position to 14,236 shares worth $2.69M. The position accounts for 0.02% of the portfolio, ranked #936.

Empowered Funds first reported a position in JAZZ in Q3 2023 and has held it in 6 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Empowered Funds held 14,236 shares of Jazz Pharmaceuticals worth $2.69M as of Q1 2026.
  • Empowered Funds bought 362 Jazz Pharmaceuticals shares in Q1 2026, an estimated $63.3K.
  • Jazz Pharmaceuticals made up 0.02% of Empowered Funds's portfolio in Q1 2026, its #936 holding.
  • Empowered Funds first reported a position in Jazz Pharmaceuticals in Q3 2023 and has held it in 6 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.